These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
50. Studies on extragonadal androgen: hormonal changes of the prostatic cancer patients on antiandrogenic therapy after orchiectomy. Fukuda Y Kobe J Med Sci; 1968 Mar; 14(1):1-23. PubMed ID: 5674440 [No Abstract] [Full Text] [Related]
51. Efficacy of primary hormone therapy for localized or locally advanced prostate cancer: results of a 10-year follow-up. Akaza H; Homma Y; Usami M; Hirao Y; Tsushima T; Okada K; Yokoyama M; Ohashi Y; Aso Y; BJU Int; 2006 Sep; 98(3):573-9. PubMed ID: 16925756 [TBL] [Abstract][Full Text] [Related]
52. Depression during hormonal treatment of prostate cancer. Rosenblatt DE; Mellow A J Am Board Fam Pract; 1995; 8(4):317-20. PubMed ID: 7572297 [No Abstract] [Full Text] [Related]
53. [Castration in the treatment of locally advanced or metastatic prostate cancer]. Mongiat-Artus P Rev Prat; 2013 Apr; 63(4):509-10. PubMed ID: 23682480 [No Abstract] [Full Text] [Related]
54. Managing hot flashes in men being treated for prostate cancer. Baum NH; Torti DC Geriatrics; 2007 Nov; 62(11):18-21. PubMed ID: 17999566 [TBL] [Abstract][Full Text] [Related]
55. Global update on defining and treating high-risk localized prostate cancer with leuprorelin: a European perspective. Boccon-Gibod L BJU Int; 2007 Jan; 99 Suppl 1():2-5; discussion 17-8. PubMed ID: 17229159 [TBL] [Abstract][Full Text] [Related]
56. [Hormonal treatment of disseminated cancer of the prostate: results and survival obtained in a series of 60 patients]. Izquierdo Font AJ; Barnadas Molins A; Germa Lluch JR; Marcuello Gaspar E; López López JJ Actas Urol Esp; 1985; 9(3):231-6. PubMed ID: 4036688 [No Abstract] [Full Text] [Related]
57. Cost comparison of orchiectomy and leuprolide in metastatic prostate cancer. Bonzani RA; Stricker HJ; Peabody JO; Menon M J Urol; 1998 Dec; 160(6 Pt 2):2446-9. PubMed ID: 9817400 [TBL] [Abstract][Full Text] [Related]
58. Raloxifene can benefit prostate cancer. Health News; 2006 Aug; 12(8):2. PubMed ID: 16917966 [No Abstract] [Full Text] [Related]
59. Characterization of the intra-prostatic immune cell infiltration in androgen-deprived prostate cancer patients. Gannon PO; Poisson AO; Delvoye N; Lapointe R; Mes-Masson AM; Saad F J Immunol Methods; 2009 Aug; 348(1-2):9-17. PubMed ID: 19552894 [TBL] [Abstract][Full Text] [Related]
60. Rebuttal from authors re: Joaquim Bellmunt. Chemotherapy for prostate cancer in senior adults: are we treating the elderly or the frail? Eur Urol 2009;55:1310-2. Italiano A; Fizazi K Eur Urol; 2009 Jun; 55(6):1313-4. PubMed ID: 18849106 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]